Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1077-1084

  Li, Qing ^a   Kopecky, Kenneth J ^c   Mohan, Avinash ^a   Willman, Cheryl L ^b,c   Appelbaum, Frederick R ^c   Weick, James K ^c   Issa, Jean Pierre J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c SW Oncology Group Statistical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METHYLATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW CELLS; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; REGRESSION ANALYSIS; TUMOR STEM CELLS;

EID: 0032949084     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J-P. J. Alterations in DNA methylation - a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
2. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
3. Issa, J-P. J., Baylin, S. B., and Herman, J. G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia (Baltimore), 11: S7-S11, 1997.
4. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
5. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
6. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res., 57: 2619-2622, 1997.
7. Martinez-Delgado, B., Fernandez-Piqueras, J., Garcia, M. J., Arranz, E., Gallego, J., Rivas, C., Robledo, M., and Benitez, J. Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia (Baltimore), 11: 425-428, 1997.
8. Batova, A., Diccianni, M. B., Yu, J. C., Nobori, T., Link, M. P., Pullen, J., and Yu, A. L. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res., 57: 832-836, 1997.
9. Issa, J-P. J., Baylin, S. B., and Belinsky, S. A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res., 56: 3655-3658, 1996.
10. Issa, J-P. J., Zehnbauer, B. A., Civin, C. I., Collector, M. I., Sharkis, S. J., Davidson, N. E., Kaufmann, S. H., and Baylin, S. B. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res., 56: 973-977, 1996.
11. Weick, J. K., Kopecky, K. J., Appelbaum, F. R., Head, D. R., Kingsbury, L. L., Balcerzak, S. P., Bickers, J. N., Hynes, H. E., Welborn, J. L., Simon, S. R., and Grever, M. A randomized investigation of high-dose versus standard-dose 1-β-D-arabinofuranosylcytosine with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood, 88: 2841-2851, 1996.
12. Cox, D. R. Analysis of Binary Data. London: Chapman and Hall, 1970.
13. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
14. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B, 34: 187-220, 1972.
15. Issa, J-P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
16. Li, Q., Jedlicka, A., Ahuja, N., Gibbons, M. C., Baylin, S. B., Burger, P. C., and Issa, J-P. J. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene, 16: 3197-3202, 1998.
17. MacGrogan, D., Levy, A., Bova, G. S., Isaacs, W. A., and Bookstein, R. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics, 35: 55-65, 1996.
18. Rowley, J. D., Aster, J. C., and Sklar, J. The clinical applications of new DNA diagnostic technology on the management of cancer patients. J. Am. Med. Assoc., 270: 2331-2337, 1993.
19. Buchner, T., and Heinecke, A. The role of prognostic factors in acute myeloid leukemia. Leukemia (Baltimore), 10 (Suppl. 1): S28-S29, 1996.
20. Ahuja, N., Mohan, A. L., Li, Q., Stoiker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., and Issa, J. P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res., 57: 3370-3374, 1997.
21. Rubin, C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M., LiVolsi, V., Berchuck, A., Muto, M., Garber, J., Weber, B., Lynch, H., and Boyd, J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of Brcal. N. Engl. J. Med., 335: 1413-1416, 1996.
22. Vogel, V. G., and Fisher, R. E. Epidemiology and etiology of leukemia. Curr. Opin. Oncol., 5: 26-34, 1993.
23. Smith, M. A., McCaffrey, R. P., and Karp, J. E. The secondary leukemias: challenges and research directions. J. Natl. Cancer Inst., 88: 407-418, 1996.
24. Kantarjian, H. M., O'Brien, S., Anderlini, P., and Talpaz, M. Treatment of myelogenous leukemia: current status and investigational options. Blood, 87: 3069-3081, 1996